Niagen Bioscience, Inc. (NAGE)
4.86
-0.08
(-1.72%)
USD |
NASDAQ |
Feb 20, 16:00
4.86
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience Profit Margin (Quarterly) : 13.47% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 9.32% |
| Nephros, Inc. | 7.07% |
| Harrow, Inc. | 1.42% |
| Astrana Health, Inc. | 0.11% |
| Clover Health Investments Corp. | -4.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 37.74% |
| Return on Assets | 25.81% |
| Return on Invested Capital | 35.70% |
| Gross Profit Margin (Quarterly) | 64.52% |
| Operating Margin (Quarterly) | 12.46% |
| Return on Net Operating Assets | 82.48% |